Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
about
HPV & head and neck cancer: a descriptive updateDe-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaHyperfractionated or accelerated radiotherapy for head and neck cancerInterventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapyInterventions for the treatment of oral and oropharyngeal cancers: surgical treatmentModern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationEffect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literatureRadiation-induced carotid artery stenosis: a comprehensive review of the literatureAn updated overview of HPV-associated head and neck carcinomasWhat is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.Human papillomavirus and survival of patients with oropharyngeal cancer.Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..The Indian scenario of head and neck oncology - Challenging the dogmasTreatment of Elderly Patients with Squamous Cell Carcinoma of the Head and NeckAn update on larynx cancerOptimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapyIntraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complicationsIn silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroidsHow individual participant data meta-analyses have influenced trial design, conduct, and analysisFound in translation: Integrating laboratory and clinical oncology researchTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized TrialsHyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reEvidence-based review of treatment options for patients with glottic cancer.Lack of influence of intravenous contrast on head and neck IMRT dose distributions.Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results.The fractionation conundrum: Are we still missing a piece of the puzzle?Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.Role and value of diffusion-weighted MRI in the radiotherapeutic management of head and neck cancer.Advances in the management of squamous cell carcinoma of the head and neck.Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocolDefinitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer.Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trialsImpact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR)Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years oldPhase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-
P2860
Q21198763-7150DD50-F186-4DCA-B19A-871A73214AB5Q24200362-F767D6D5-B054-4742-A819-F6B8063CD0D0Q24235527-61A38923-B11D-4EED-A574-A4C768EAC7CBQ24235741-42A86697-D4CA-422E-A3EB-584F799E8275Q24242951-6E637EF6-8437-4566-8B73-C6192BF39C64Q26744490-C2CD680F-D597-4205-83EC-EA27909677A6Q26779472-C33360DB-9D3B-4AE1-9578-9E7ECA3E439CQ26858921-9E68485D-96BC-4FBC-AAB6-0C8C5E1173CFQ27014019-A53CDB47-DB82-4AD3-9086-17B0B165C2F9Q27026269-745B74C3-C407-42BC-BB16-68AC74CB639AQ27313572-BEA2A9CD-B963-4341-B58A-92FE3A47F153Q27851567-998F38CE-2BA0-4209-BE7F-47078F17D3FDQ27853302-BF2515F4-09A1-48A3-860A-18C35541444BQ28072546-42B7C350-BA48-416B-A942-C46642950B6FQ28076894-44BACAC6-8DA8-4700-B98A-4D41A3718044Q28079132-6A808607-1178-4346-B774-43894B2D4C7CQ28083540-268CAF50-1B4B-40DF-8C2C-D4551C6A3B3EQ28282290-9FC4DE90-C4A3-4F3D-BDAD-70666BBB33F5Q28535111-B87AC03A-2B72-41C0-A0C8-53921AEEB698Q28607751-C44E44E6-7E5C-455C-84C6-2B3CB1712F76Q28744471-ED164613-7290-4E74-9EAA-FE7A8C3F8FB5Q30248577-D078E992-3BFC-40F1-B6EB-FAFB430F8DFAQ30252081-056E3DC8-20C1-416F-871C-79232FC9EC64Q30278410-81C579BC-47A7-40F7-8DBF-2E6F0F14D04EQ30313175-B9B87368-56E9-40C3-8E4A-93F390A50FB1Q30363946-E16ADFE8-8ECF-4625-8349-1E1DE024F5F2Q31032091-CF993247-6B52-4AF2-AC68-B4567BDC419FQ33302524-945B35F9-742A-47FD-B575-5B5BF981D204Q33353609-0D8D324C-6263-4BEE-9814-23EFBE2203DEQ33357621-ECAB4487-8603-4EBC-BC08-F53C86E247C4Q33412010-6A511B33-FA5E-4B41-A9C1-94872E6B8789Q33690816-FB7DA2A1-84AA-432E-8196-88F08F33F8BDQ33720431-C038D306-DD85-48E3-AD9C-FB35979687DBQ33721749-73348758-E8D8-4C6F-BBB5-EFA785669DA6Q33756191-4E7155C5-EC79-4463-A4EA-78FA2268A538Q33770819-F055147B-FEB8-418C-9108-6B089D75E34CQ33813067-DFED5C41-A641-4651-9F7A-C5A7E2130514Q33844620-651B1F7E-B75C-45EF-9FC1-647D2B3CD6E3Q33869454-4D11E153-2679-4FEF-8815-9DAFE8DC52B6Q33906160-D8082EE0-E088-483A-8138-4569FDE0C7C1
P2860
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@ast
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@en
type
label
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@ast
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@en
prefLabel
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@ast
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@en
P2093
P1433
P1476
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
@en
P2093
Andrzej Hliniak
Aurélie Le Maître
Carlo Fallai
Hélène Audry
Jacques Bernier
Jean Bourhis
Jean-Claude Horiot
Jens Overgaard
John H Hay
Karen K Fu
P304
P356
10.1016/S0140-6736(06)69121-6
P407
P577
2006-09-01T00:00:00Z